Tag: COVID19

Five ways to sustain the hepatitis C elimination efforts in Canada

This June, CATIE and the Canadian Network on Hepatitis C (CanHepC) co-hosted a webinar on sustaining the hepatitis C response before and after the novel coronavirus disease (COVID-19) pandemic. We invited leaders in the hepatitis C field to explore the challenges that the pandemic has posed for hepatitis C elimination efforts, but also the opportunities that could be leveraged. Here are just five of the ways we can do this:

Read more

The challenges of STI testing during COVID-19

Nova Scotia is no stranger to syphilis. Back in 2012, the province saw a spike in cases – almost double compared to the year before. In early 2020, another outbreak was identified with a 60% increase between 2018 and 2019. This latest outbreak was different in two key ways: it was predominantly among women, and not focused solely in Halifax.

Read more

Gendering the Scene: We need to listen to women and gender-diverse people who use drugs

Over the past several years, Canada has been in the grip of an overdose crisis. We have seen the devastating effects both of a contaminated drug supply and of punitive laws that restrict access of people who use drugs to effective treatment and support. Now we are facing the twin crisis of the novel coronavirus disease (COVID-19) pandemic, which has radically altered the way we interact with one another and affected the drug supply chain.

Read more